J M Allen

1.3k total citations
8 papers, 1.1k citations indexed

About

J M Allen is a scholar working on Molecular Biology, Reproductive Medicine and Organic Chemistry. According to data from OpenAlex, J M Allen has authored 8 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Reproductive Medicine and 2 papers in Organic Chemistry. Recurrent topics in J M Allen's work include Hypothalamic control of reproductive hormones (3 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Quinazolinone synthesis and applications (2 papers). J M Allen is often cited by papers focused on Hypothalamic control of reproductive hormones (3 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Quinazolinone synthesis and applications (2 papers). J M Allen collaborates with scholars based in United Kingdom, United States and France. J M Allen's co-authors include Bert W. O’Malley, James H. Clark, Jon Curwen, Patrick A. Plé, Gerard Costello, Laurent Hennequin, Tim P. Green, Shailaja K. Mani, Christine Lambert‐van der Brempt and Michael Fennell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

J M Allen

8 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J M Allen United Kingdom 7 402 252 217 204 168 8 1.1k
B. K. Lucas France 9 822 2.0× 205 0.8× 464 2.1× 340 1.7× 77 0.5× 10 1.7k
Judit Érchegyi United States 20 470 1.2× 117 0.5× 518 2.4× 93 0.5× 53 0.3× 38 1.4k
Fabrice Vandeput United States 16 1.3k 3.1× 1.1k 4.3× 115 0.5× 246 1.2× 49 0.3× 21 1.9k
Jean-Pierre Morello Canada 8 1.6k 3.9× 82 0.3× 104 0.5× 86 0.4× 57 0.3× 9 2.0k
Rebecca M. Perrett United Kingdom 16 810 2.0× 118 0.5× 166 0.8× 192 0.9× 25 0.1× 26 1.1k
André Laperrière Canada 9 1.1k 2.6× 77 0.3× 62 0.3× 80 0.4× 23 0.1× 9 1.3k
Joyce C. Wu United States 16 905 2.3× 210 0.8× 180 0.8× 242 1.2× 24 0.1× 20 1.5k
Yasushi Masuda Japan 15 795 2.0× 250 1.0× 67 0.3× 51 0.3× 15 0.1× 30 1.3k
Parvathi Nuthulaganti United States 13 536 1.3× 112 0.4× 48 0.2× 54 0.3× 17 0.1× 20 999
Josefa Andrade United States 13 719 1.8× 96 0.4× 111 0.5× 193 0.9× 9 0.1× 19 1.1k

Countries citing papers authored by J M Allen

Since Specialization
Citations

This map shows the geographic impact of J M Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J M Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J M Allen more than expected).

Fields of papers citing papers by J M Allen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J M Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J M Allen. The network helps show where J M Allen may publish in the future.

Co-authorship network of co-authors of J M Allen

This figure shows the co-authorship network connecting the top 25 collaborators of J M Allen. A scholar is included among the top collaborators of J M Allen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J M Allen. J M Allen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Green, Tim P., Jon Curwen, Vivien N. Jacobs, et al.. (2009). Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530. Molecular Oncology. 3(3). 248–261. 176 indexed citations
3.
Freeman, S, et al.. (2006). Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme. British Journal of Pharmacology. 149(6). 775–785. 22 indexed citations
4.
Plé, Patrick A., Tim P. Green, Laurent Hennequin, et al.. (2004). Discovery of a New Class of Anilinoquinazoline Inhibitors with High Affinity and Specificity for the Tyrosine Kinase Domain of c-Src. Journal of Medicinal Chemistry. 47(4). 871–887. 139 indexed citations
5.
Fennell, Michael, Jon Curwen, J M Allen, et al.. (2004). 361 Preclinical activity of AZD0530, a novel, oral, potent and selective inhibitor of the Src family kinases. European Journal of Cancer Supplements. 2(8). 109–109. 6 indexed citations
6.
Mani, Shailaja K., J M Allen, John P. Lydon, et al.. (1996). Dopamine requires the unoccupied progesterone receptor to induce sexual behavior in mice.. Molecular Endocrinology. 10(12). 1728–1737. 144 indexed citations
7.
Mani, Shailaja K., J M Allen, Valéria Rettori, et al.. (1994). Nitric oxide mediates sexual behavior in female rats.. Proceedings of the National Academy of Sciences. 91(14). 6468–6472. 152 indexed citations
8.
Mani, Shaila K., Jeffrey D. Blaustein, J M Allen, et al.. (1994). Inhibition of rat sexual behavior by antisense oligonucleotides to the progesterone receptor.. Endocrinology. 135(4). 1409–1414. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026